Riyadh — Mubasher: Al Razi Medical Company reported a 261.27% surge in net profit to nearly SAR 420,000 during the first half (H1) of 2026, compared to roughly SAR 120,000 during the same period in 2025.
The medical company’s revenues rose by 5.92% to SAR 36 million in H1-26 from SAR 33.99 million in H1-25, according to a bourse filing.
Al Razi Medical attributed the January-June revenue growth primarily to increased contributions from new branches. This expansion in the top line was the main driver behind the significant improvement in the bottom line.
Earnings per share (EPS) for the period increased to SAR 0.28 from SAR 0.08 in H1-25.
Total shareholders' equity, excluding non-controlling interests, stood at SAR 23.92 million at the end of the period, representing a 5.20% increase from SAR 22.74 million a year earlier.
It is worth noting that the external auditor’s report was issued with an unmodified opinion.
